To explore the effect of SETDB1 loss of function on AML cells, we mined data from a recent study that utilized CRISPR-Cas9 targeting of SETDB1 in the human MLL-AF9 driven AML cell line, THP-1 [58]. This evidence concerns the gene SETDB1 and acute myeloid leukemia.